ProShare Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q3 | – | Sell |
-28,128
| Closed | -$421K | – | 1572 |
|
2016
Q2 | $421K | Buy |
28,128
+599
| +2% | +$8.97K | 0.01% | 1044 |
|
2016
Q1 | $335K | Sell |
27,529
-2,654
| -9% | -$32.3K | ﹤0.01% | 1156 |
|
2015
Q4 | $480K | Buy |
30,183
+2,691
| +10% | +$42.8K | 0.01% | 1052 |
|
2015
Q3 | $421K | Sell |
27,492
-1,353
| -5% | -$20.7K | 0.01% | 990 |
|
2015
Q2 | $701K | Sell |
28,845
-1,702
| -6% | -$41.4K | 0.01% | 943 |
|
2015
Q1 | $710K | Buy |
30,547
+4,154
| +16% | +$96.6K | 0.01% | 1018 |
|
2014
Q4 | $663K | Buy |
26,393
+702
| +3% | +$17.6K | 0.01% | 1074 |
|
2014
Q3 | $799K | Sell |
25,691
-4,292
| -14% | -$133K | 0.01% | 1157 |
|
2014
Q2 | $775K | Sell |
29,983
-13,394
| -31% | -$346K | 0.01% | 1301 |
|
2014
Q1 | $1.01M | Buy |
43,377
+28,042
| +183% | +$656K | 0.01% | 1300 |
|
2013
Q4 | $389K | Buy |
15,335
+4,794
| +45% | +$122K | 0.01% | 1102 |
|
2013
Q3 | $215K | Buy |
+10,541
| New | +$215K | 0.01% | 2147 |
|